Mapping of tissue tropism determinants in coxsackievirus genomes

Journal of General Virology

Volumn 83, Issue 7, 2002, Pages 1697-1706

  Harvala, Heli ^a   Kalimo, Hannu ^a   Dahllund, Leif ^a   Santti, Juhana ^a   Hughes, Pamela ^a   Hyypiä, Timo ^a   Stanway, Glyn ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; UNTRANSLATED RNA; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CENTRAL NERVOUS SYSTEM INFECTION; CHIMERA; CONTROLLED STUDY; COXSACKIE VIRUS A; COXSACKIE VIRUS B3; GENE MAPPING; GENE SEQUENCE; GENE STRUCTURE; GENETIC CODE; HEPATITIS; IN SITU HYBRIDIZATION; MOLECULAR CLONING; MOLECULAR RECOGNITION; MOUSE; MUSCLE TISSUE; MYOSITIS; NEUROTROPISM; NEWBORN; NONHUMAN; PANCREAS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SKELETAL MUSCLE; TISSUE GROWTH; VIRUS CAPSID; VIRUS GENOME; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALIA; COXSACKIEVIRUS; RNA VIRUSES;

EID: 0036297140     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-7-1697     Document Type: Article

References (44)

1. Intracellular determinants of picornavirus replication
2. Experimental myocarditis induced by two different coxsackievirus B3 variant: Aspects of pathogenesis and comparison of diagnostic methods
3. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55)
4. Isolation of common receptor for coxsackie B viruses and adenovirus 2 and 5
5. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses
6. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype
7. The nucleotide sequence of coxsackievirus A9 - Implication for receptor binding and enterovirus classification
8. A group B coxsackievirus/poliovirus 5′ nontranslated region chimera can act as an attenuated vaccine strain in mice
9. Coxsackieviruses
10. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: Localization to the 5′ nontranslated region
11. A single nucleotide change in the 5′ non-coding region of the genome of the Sabin type 3 poliovaccine is associated with increased neurovirulence
12. Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis
13. Poliovirus receptor on human blood cells: A possible extraneural site of poliovirus replication
14. Interactions of viral protein 3CD and poly(rC) binding protein with the 5′ untranslated region of the poliovirus genome
15. Enteroviruses in human disease
16. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence
17. Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: Implications for the pathogenesis of poliomyelitis
18. Relative abundance of enterovirus serotypes in sewage differs from that in patients: Clinical and epidemiological implications
19. The coxsackievirus A9 RGD motif is not essential for virus viability
20. Pathogenetic differences between coxsackie A and B virus infections in newborn mice
21. Classification of enteroviruses based on molecular and biological properties
22. Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells
23. Picornaviridae
24. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: Two initial 5′ uridine residues are regained during plus-strand RNA synthesis
25. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3
26. Transgenic mice susceptible to poliovirus
27. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3
28. Coxsackievirus infection of the pancreas: Evaluation of receptor expression, pathogenesis, and immunopathology
29. The molecular biology of poliovaccines
30. Enteroviruses, including polioviruses
31. Molecular comparison of coxsackie A virus serotypes
32. A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence
33. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice
34. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis
35. Identification of two determinants that attenuate vaccine-related type 2 poliovirus
36. Molecular determinants for virulence in coxsackievirus B1 infection
37. RGD-dependent entry of coxsackievirus A9 into host cell and its bypass after cleavage of VP1 protein by intestinal proteases
38. Entry of coxsackievirus A9 into host cells: Specific interactions with αvβ3 integrin, the virtonectin receptor
39. Evidence of recombination among enteroviruses
40. Molecular epidemiology and evolution of coxsackievirus A9
41. Attachment of coxsackievirus B3 variants to various cell lines: Mapping of phenotype differences to capsid protein VP1
42. 472 → U
43. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region
44. Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies